<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Korean Med Sci</journal-id>
      <journal-id journal-id-type="iso-abbrev">J. Korean Med. Sci</journal-id>
      <journal-id journal-id-type="publisher-id">JKMS</journal-id>
      <journal-title-group>
        <journal-title>Journal of Korean Medical Science</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-8934</issn>
      <issn pub-type="epub">1598-6357</issn>
      <publisher>
        <publisher-name>The Korean Academy of Medical Sciences</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23400265</article-id>
      <article-id pub-id-type="pmc">3565150</article-id>
      <article-id pub-id-type="doi">10.3346/jkms.2013.28.2.336</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
          <subj-group>
            <subject>Nephrology</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Electrolyte Imbalances and Nephrocalcinosis in Acute Phosphate Poisoning on Chronic Type 1 Renal Tubular Acidosis due to Sj&#xF6;gren's Syndrome</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>Sung-Gun</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Yi</surname>
            <given-names>Joo-Hark</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Han</surname>
            <given-names>Sang-Woong</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Ho-Jung</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Renal Division, Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea.</aff>
      <author-notes>
        <corresp>
Address for Correspondence: Joo-Hark Yi, MD. Renal Division, Department of Internal Medicine, Hanyang University Guri Hospital, 153 Gyeongchun-ro, Guri 471-701, Korea. Tel: +82.31-560-2186, Fax: +82.31-566-0801, <email>Joohark@hanyang.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>1</month>
        <year>2013</year>
      </pub-date>
      <volume>28</volume>
      <issue>2</issue>
      <fpage>336</fpage>
      <lpage>339</lpage>
      <history>
        <date date-type="received">
          <day>05</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>07</day>
          <month>12</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2013 The Korean Academy of Medical Sciences.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Although renal calcium crystal deposits (nephrocalcinosis) may occur in acute phosphate poisoning as well as type 1 renal tubular acidosis (RTA), hyperphosphatemic hypocalcemia is common in the former while normocalcemic hypokalemia is typical in the latter. Here, as a unique coexistence of these two seperated clinical entities, we report a 30-yr-old woman presenting with carpal spasm related to hypocalcemia (ionized calcium of 1.90 mM/L) due to acute phosphate poisoning after oral sodium phosphate bowel preparation, which resolved rapidly after calcium gluconate intravenously. Subsequently, type 1 RTA due to Sj&#xF6;gren's syndrome was unveiled by sustained hypokalemia (3.3 to 3.4 mEq/L), persistent alkaline urine pH (&gt; 6.0) despite metabolic acidosis, and medullary nephrocalcinosis. Through this case report, the differential points of nephrocalcinosis and electrolyte imbalances between them are discussed, and focused more on diagnostic tests and managements of type 1 RTA.</p>
      </abstract>
      <kwd-group>
        <kwd>Hypocalcemia</kwd>
        <kwd>Nephrocalcinosis</kwd>
        <kwd>Sodium Phosphate</kwd>
        <kwd>Distal RTA</kwd>
        <kwd>Sj&#xF6;gren's Syndrome</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Despite the diverse etiologies of renal parenchymal calcification (nephrocalcinosis), nephrocalcinosis combined with electrolyte imbalance of hypokalemia can narrow down the differential diagnosis into hereditary tubulopathy such as Bartter's syndrome, chronic laxative or diuretic abuse, type 1 renal tubular acidosis (RTA), and recently recognized acute phosphate poisoning such as oral sodium phosphate bowel preparation (OSPBP) (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>).</p>
      <p>Since the first introduction of an unusual form of cortical nephrocalcinosis due to "acute phosphate nephropathy" by Desmeules et al. (<xref ref-type="bibr" rid="B2">2</xref>) in 2003, OSP-BP associated acute or chronic renal injury has been documented in several other reports (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B3">3</xref>). Also, transient hypocalcemia and hypokalemia after OSP-BP was noted as electrolyte imbalances in more than 50% of elderly patients (<xref ref-type="bibr" rid="B4">4</xref>). In contrast, the prominent clinical features of type 1 RTA are characterized by medullary nephrocalcinosis/urolithiasis and bone involvement due to sustained hypokalemia and metabolic acidosis.</p>
      <p>In the present case, the unique clinical experience of acute phosphate poisoning after OSP-BP leading to the disclosure of previously unrecognized chronic type 1 RTA due to Sj&#xF6;gren's syndrome is introduced.</p>
    </sec>
    <sec>
      <title>CASE DESCRIPTION</title>
      <p>A 30-yr-old woman presented to the emergency department (ED) in extreme mental agitation with the recent onset of carpal spasm, a tingling sensation in the lower extremities, and circumoral numbness about 2 hr after the second dose of oral sodium phosphate (OSP) on March 14, 2012, which she took for the bowel preparation of a screening colonoscopy. She had watery diarrhea twice with abdominal discomfort before presentation to ED.</p>
      <p>In ED, vital signs were stable but with a respiratory rate of 24/min, and other physical examinations were unremarkable except for the presenting neuromusclar manifestations of hypocalcemia including the positive Chvostek's sign. As shown in <xref ref-type="table" rid="T1">Table 1</xref>, laboratory findings with normal kidney function in ED were hyperphosphatemia (9.5 mg/dL; normal, 2.5-4.5 mg/dL), hypocalcemia (total calcium of 6.5 mg/dL and ionized calcium of 1.90 mM/L; normal, 2.26-2.64 mM/L), hypokalemia (3.3 mEq/L), and respiratory alkalosis (alkaline arterial pH, 7.53; bicarbonate, 21.1 mEq/L; PCO<sub>2</sub>, 24.8 mmHg). After the intravenous injection of 1 gram of calcium gluconate in ED, carpal spasm resolved rapidly, and hyperphosphatemic hypocalcemia was no longer noticed. On subsequent hospital days (day 2 and 3), however, sustained hypokalemia (3.3 to 3.4 mEq/L) with inappropriately high transtubular potassium gradient (&#x2265; 7.0) suggesting renal potassium wasting despite dietary potassium supplementation, metabolic acidosis with normal blood anion gap (9 to 11 mEq/L; reference, 10 &#xB1; 2 mEq/L), and alkaline urine pH (&gt; 6.0) with positive urine anion gap (&gt; 16 mEq/L) suggested type 1 RTA, which was ascertained by other positive evidences for the impaired urinary acidification of distal tubules by loopdiuretic (torsemide) test (urine pH &gt; 6.5) and urine to blood PCO<sub>2</sub> gradient (&gt; 20 mmHg) upon intravenous alkali load with sodium bicarbonate.</p>
      <p>On further questioning in careful history taking, she admitted chronic gritty sensation of eyes using artificial eye drops frequently and dry mouth with polydipsia and polyuria more than 5 yr, which suggested an impaired exocrine gland secretion mostly due to Sj&#xF6;gren's syndrome. Also, keratoconjunctivitis sicca was confirmed by Schirmer's test. Furthermore, several autoantibodies for Sj&#xF6;gren's syndrome were positive with high titers; antinuclear antibodies, antibodies to the ribonucleoprotein antigen La (SS-B) and Ro (SS-A), and rheumatic factor. In imaging tests, the subsequent abdominal ultrasonography revealed prominent medullary nephrocalcinosis (<xref ref-type="fig" rid="F1">Fig. 1</xref>), and the salivary scintigraphy showed the evidence of salivary gland dysfunction in both submandibular and parotid glands (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Therefore, the secondary type 1 RTA due to Sj&#xF6;gren's syndrome was diagnosed. Subsequently, oral intake of potassium citrate (Urocitra-K&#xAE;, 1,080 mg/tablet) was initiated, of which dose was adjusted for the adequate alkali supplementation as well as for the correction of hypokalemia. Since then, hypokalemia and metabolic acidosis were no longer noticed.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Carpal spasm in this patient is most likely caused by hypocalcemia because of the transient hyperphosphatemia leading to the precipitation of calcium-phosphate complexes with acute phosphate poisoning after the use of OSP-BP. The supportive evidence is the presence of hyperphosphatemic hypocalcemia on presentation with the complete resolution of the symptoms and hyperphosphatemia within 2 hr of admission (<xref ref-type="table" rid="T1">Table 1</xref>). Also, the acute respiratory alkalosis (pH 7.53, PCO<sub>2</sub> 24.8 mmHg) as a result of the extreme mental agitation caused by the presenting neurological symptoms probably further contributed to a reduction in free ionized calcium concentration (<xref ref-type="bibr" rid="B5">5</xref>).</p>
      <p>Because of the lower cost and the better tolerance, OSP remains popular in the bowel preparation for colonoscopy in clinical practice. However, the bowel preparation using OSP is often associated with mild to severe electrolyte imbalances, such as hyperphosphatemia, hypocalcemia, hypernatremia, hyponatremia, hypokalemia, and high anion-gap metabolic acidosis. Even acute and subsequent chronic renal injury due to "phosphate nephropathy" has been observed (<xref ref-type="bibr" rid="B1">1</xref>). Deposition of calcium-phosphate crystals in distal renal tubules after OSP can be only proven by renal biopsy since the intrarenal deposition in acute hyperphosphatemia is usually not sufficient to be detectable in radiological imaging (<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B6">6</xref>). Furthermore, nephrocalcinosis associated with acute phosphate nephropathy is more predominantly localized in the renal cortex than medulla. The medullary nephrocalcinosis as in this case (<xref ref-type="fig" rid="F1">Fig. 1</xref>) is seen usually with sustained hypercalcemia and/or hypercalciuria related to malignancy, hyperparathyroidism, furosemide or laxative abuse, sarcoidosis, Type 1 RTA, etc (<xref ref-type="bibr" rid="B3">3</xref>).</p>
      <p>Following the admission, as shown in <xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Fig. 1</xref>, sustained hypokalemia with renal potassium loss (high transtubular potassium gradient (TTKG) &#x2265; 7.0), normal anion-gap metabolic acidosis, the persistent urine pH &gt; 6.0 in the presence of metabolic acidosis, and medullary nephrocalcinosis suggested the impaired distal urinary acidification due to type 1 RTA (<xref ref-type="bibr" rid="B7">7</xref>). The classical test using oral ammonium-chloride loading to assess the impaired distal urinary acidification was not performed because of the substantial pre-existing systemic acidemia. Instead, the oral administration of torsemide rather than furosemide, recently known to be more specific in assessing urinary acidification of the distal nephron in a study, showed sustained alkaline urine pH more than 6.5 (<xref ref-type="bibr" rid="B8">8</xref>). Furthermore, the sodium bicarbonate (NaHCO<sub>3</sub>) loading test also revealed the urine-to-blood PCO<sub>2</sub> gradient that was persistently less than 11.2 mmHg when the urine pH (7.62) exceeded the corresponding blood pH (7.39) (<xref ref-type="bibr" rid="B9">9</xref>). Hence, there is little doubt for the certainty of the diagnosis of type 1 RTA in this patient.</p>
      <p>Approximately 10% of the patients with Sj&#xF6;gren's syndrome have clinically significant renal disease. The renal involvement of the disease is often associated with RTA (33%), predominantly type 1 RTA and less frequently type 2 RTA (<xref ref-type="bibr" rid="B10">10</xref>). In an immunocytochemical study, the absence or decrease of H<sup>+</sup>-ATPase in the intercalated cells of cortical collecting tubules of distal nephron has been shown, and appears to play an important role in the pathogenesis of type 1 RTA in patients with Sj&#xF6;gren's syndrome (<xref ref-type="bibr" rid="B11">11</xref>).</p>
      <p>Is it likely that the underlying type 1 RTA contributed to acute hypocalcemia? Chronic metabolic acidosis results in negative calcium balance due to the renal wasting of calcium (<xref ref-type="bibr" rid="B12">12</xref>). Although serum calcium is usually maintained within normal limits because of the compensating secondary hyperparathyroidism, the ionized calcium concentration in the serum must be lower than usual in the presence of chronic metabolic acidosis in order to induce secondary hyperparathyroidism. Thus, any additional factor that reduces serum calcium such as acute hyperphosphatemia as in this case would have a greater hypocalcemic effect in an untreated patient with type 1 RTA.</p>
      <p>The major underlying mechanism of nephrocalcinosis in type 1 RTA is metabolic acidosis: chronic metabolic acidosis stimulates bone resorption and impairs renal tubular reabsorption of calcium, both of which contribute to hypercalciuria; nephrocalcinosis is further aggravated by a low urinary citrate excretion, which in the case of type 1 RTA is due to metabolic acidosis and hypokalemia; metabolic acidosis leads to hypokalemia because of the increased delivery of sodium to the cortical collecting duct and the stimulation of aldosterone (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B14">14</xref>). Hence, the mainstay of the treatment for nephrocalcinosis is to prevent its progression by correcting the biochemical abnormalities associated with type 1 RTA.</p>
      <p>The presence of hypokalemia in type 1 RTA by inducing low intracellular pH of the proximal tubular cells contributes to decreased excretion of urinary citrate (<xref ref-type="bibr" rid="B14">14</xref>). That explains why urinary citrate excretion is not reduced in type 4 RTA. In fact, the increase in citrate excretion following the administration of potassium citrate is the result of correction of metabolic acidosis, not the citrate administration per se. Although potassium bicarbonate for the therapy of type 1 RTA can be equally effective, it causes more side effects, such as gas formation of CO<sub>2</sub> in the stomach as bicarbonate reacts with HCl. Therefore, potassium citrate by either as a drug or from natural food sources including beverages would be an ideal substance for adequate alkali supplementation (1-2 mM/kg/d in adults) and for the correction of hypokalemia and hypocitraturia as well.</p>
      <p>In summary, the precipitation of calcium-phosphate complexes by acute hyperphosphatemia after OSP-BP caused acute hypocalcemia, which was further aggravated by acute respiratory alkalosis, leading to the manifestation of hypocalcemic tetany. Subsequently, the sustained hypokalemia, nephrocalcinosis in medulla, and biochemical findings of impaired ability of urinary acidification unveiled the secondary type 1 RTA due to Sj&#xF6;gren's syndrome.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>ACKNOWLEDGMENTS</title>
      <p>The authors deeply appreciate Dr. Man S. Oh, Dept. of Internal Medicine, State University of New York at Brooklyn for his sincere comments and critical reading of the manuscript.</p>
    </ack>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heher</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Thier</surname>
              <given-names>SO</given-names>
            </name>
            <name>
              <surname>Rennke</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Humphreys</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>Adverse renal and metabolic effects associated with oral sodium phosphate bowel preparation</article-title>
          <source>Clin J Am Soc Nephrol</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>1494</fpage>
          <lpage>1503</lpage>
          <pub-id pub-id-type="pmid">18596115</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Desmeules</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gergeron</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Isenring</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Acute phosphate nephropathy and renal failure</article-title>
          <source>N Engl J Med</source>
          <year>2003</year>
          <volume>349</volume>
          <fpage>1006</fpage>
          <lpage>1007</lpage>
          <pub-id pub-id-type="pmid">12954755</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Markowitz</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Perazella</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Acute phosphate nephropathy</article-title>
          <source>Kidney Int</source>
          <year>2009</year>
          <volume>76</volume>
          <fpage>1027</fpage>
          <lpage>1034</lpage>
          <pub-id pub-id-type="pmid">19675530</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beloosesky</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Grinblat</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Grosman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gafter</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Chagnac</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Electrolyte disorders following oral sodium phosphate administration for bowel cleansing in elderly patients</article-title>
          <source>Arch Intern Med</source>
          <year>2003</year>
          <volume>163</volume>
          <fpage>803</fpage>
          <lpage>808</lpage>
          <pub-id pub-id-type="pmid">12695271</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seamonds</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Towfighi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Arvan</surname>
              <given-names>DA</given-names>
            </name>
          </person-group>
          <article-title>Determination of ionized calcium in serum by use of an ion-selective electrode. I. Determination of normal values under physiologic conditions, with comments on the effects of food ingestion and hyperventilation</article-title>
          <source>Clin Chem</source>
          <year>1972</year>
          <volume>18</volume>
          <fpage>155</fpage>
          <lpage>160</lpage>
          <pub-id pub-id-type="pmid">5008523</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Joo</surname>
              <given-names>WC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>JY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>A case of biopsy-proven chronic kidney disease on progression from acute phosphate nephropathy</article-title>
          <source>Kidney Res Clin Pract</source>
          <year>2012</year>
          <volume>31</volume>
          <fpage>124</fpage>
          <lpage>127</lpage>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rodriguez Soriano</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Renal tubular acidosis: the clinical entity</article-title>
          <source>J Am Soc Nephrol</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>2160</fpage>
          <lpage>2170</lpage>
          <pub-id pub-id-type="pmid">12138150</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Oh</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Comparison of the urine acidification tests of torsemide vs furosemide in healthy volunteers</article-title>
          <source>Nephrol Dial Transplant</source>
          <year>2005</year>
          <volume>20</volume>
          <fpage>2582</fpage>
          <lpage>2583</lpage>
          <pub-id pub-id-type="pmid">16115850</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halperin</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Haig</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Stinebaugh</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Studies on the pathogenesis of type I (distal) renal tubular acidosis as revealed by the urinary PCO2 tensions</article-title>
          <source>J Clin Invest</source>
          <year>1974</year>
          <volume>53</volume>
          <fpage>669</fpage>
          <lpage>677</lpage>
          <pub-id pub-id-type="pmid">4812435</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maripuri</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Grande</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Osborn</surname>
              <given-names>TG</given-names>
            </name>
            <name>
              <surname>Fervenza</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Matteson</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Donadio</surname>
              <given-names>JV</given-names>
            </name>
            <name>
              <surname>Hogan</surname>
              <given-names>MC</given-names>
            </name>
          </person-group>
          <article-title>Renal involvement in primary Sj&#xF6;gren's syndrome: a clinicopathologic study</article-title>
          <source>Clin J Am Soc Nephrol</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>1423</fpage>
          <lpage>1431</lpage>
          <pub-id pub-id-type="pmid">19679669</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Bastani</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kolner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hemken</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gluck</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Absence of H<sup>+</sup>-ATPase in cortical collecting tubules of a patient with Sjogren's syndrome and distal renal tubular acidosis</article-title>
          <source>J Am Soc Nephrol</source>
          <year>1992</year>
          <volume>3</volume>
          <fpage>264</fpage>
          <lpage>271</lpage>
          <pub-id pub-id-type="pmid">1391725</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albright</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Burnett</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Parson</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Reifenstein</surname>
              <given-names>EC</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Roos</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Osteomalacia and late rickets: The various etiologies met in the United States with emphasis on that resulting from a specific form of renal acidosis, the therapeutic indications for each etiological sub-group, and the relationship between osteomalacia and Milkman's syndrome</article-title>
          <source>Medicine</source>
          <year>1946</year>
          <volume>25</volume>
          <fpage>399</fpage>
          <lpage>479</lpage>
          <pub-id pub-id-type="pmid">20278772</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fourman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>JR</given-names>
            </name>
          </person-group>
          <article-title>Diminished urinary excretion of citrate during deficiencies of potassium in man</article-title>
          <source>Lancet</source>
          <year>1953</year>
          <volume>265</volume>
          <fpage>656</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="pmid">13098034</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Halperin</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Carlisle</surname>
              <given-names>EJF</given-names>
            </name>
            <name>
              <surname>Donnely</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Kamel</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Vasuvattakul</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Narins</surname>
              <given-names>RG</given-names>
            </name>
          </person-group>
          <article-title>Renal tubular acidosis</article-title>
          <source>Maxwell and Cleeman's Clinical Disorders of Fluid and Electrolyte Metabolism</source>
          <year>1994</year>
          <edition>5th ed</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>McGraw-Hill Incorporated</publisher-name>
          <fpage>875</fpage>
          <lpage>910</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Renal ultrasonogram showing hyperechogenic areas in the medulla of the right kidney, indicating medullary nephrocalcinosis.</p>
      </caption>
      <graphic xlink:href="jkms-28-336-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>Salivary scintigram showing almost no uptake in the submandibular glands and slightly decreased salivary uptake, as well as delayed excretion in the parotid glands.</p>
      </caption>
      <graphic xlink:href="jkms-28-336-g002"/>
    </fig>
    <table-wrap id="T1" position="float">
      <label>Table 1</label>
      <caption>
        <p>Laboratory data</p>
      </caption>
      <graphic xlink:href="jkms-28-336-i001"/>
      <table-wrap-foot>
        <fn>
          <p><sup>*</sup>Anion gap (blood) = [Na<sup>+</sup>] - ([Cl<sup>-</sup>] + [HCO<sub>3</sub><sup>-</sup>]); <sup>&#x2020;</sup>Anion gap (urine) = ([Na<sup>+</sup>] + [K<sup>+</sup>]) - [Cl<sup>-</sup>]. ED, emergency department; BUN, blood urea nitrogen; TTKG, transtubular potassium gradient.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
